Scientific Remedies PimoBuddy 1.25/2.5mg Tablets For Dogs
Inclusive of all taxes
Product Details
| Product type | Oral Tablets |
| Volume / Quantity | Pack of 30 Tablets (Typically packaged as 3 strips of 10 tablets per box) |
| Target Species | Canines Only (Dogs diagnosed with early-to-moderate clinical valvular insufficiency or cardiac expansion) |
| Common Use Case | Long-term therapeutic regulation of clinical congestive heart failure (CHF) resulting from Myxomatous Mitral Valve Disease (MMVD) or Dilated Cardiomyopathy (DCM); reduction of systemic vascular resistance; management of arterial hypertension; and offering renoprotective or end-organ defense to improve daily stamina, breathing comfort, and overall life expectancy. |
Scientific Remedies PimoBuddy 1.25/2.5mg is a prescription-only veterinary dual-action cardiovascular medication designed for the management of mild to moderate congestive heart failure (CHF) and structural heart disease in dogs. This specialized formulation delivers a precise, low-dose fixed combination of Pimobendan (1.25mg) and Benazepril Hydrochloride (2.5mg). Together, these active ingredients lower blood pressure, reduce structural heart strain, and protect vital organs from progressive decline.
Pimobendan works as a positive "inodilator" by acting as a calcium sensitizer to directly improve heart muscle contractility while selectively inhibiting the phosphodiesterase III (PDE3) enzyme to dilate systemic blood vessels. Simultaneously, Benazepril Hydrochloride operates as an Angiotensin-Converting Enzyme (ACE) inhibitor that blocks the renin-angiotensin-aldosterone system (RAAS), preventing the conversion of angiotensin I to angiotensin II to naturally relax arterial pathways. This synergistic dual mechanism efficiently lowers both preload and afterload on weakened heart chambers without dangerously escalating myocardial oxygen consumption. It is highly effective for smaller to medium-sized dog breeds suffering from congestive heart failure secondary to Myxomatous Mitral Valve Disease (MMVD) or Dilated Cardiomyopathy (DCM). By smoothly controlling cardiac output and offering renal protection via reduced glomerular filtration pressure, PimoBuddy significantly alleviates life-limiting symptoms like chronic coughing, lethargy, and breathing difficulties.